Guangdong Biolight Meditech Co., Ltd.

Shenzhen Stock Exchange 300246.SZ

Guangdong Biolight Meditech Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD -12.86 M

Guangdong Biolight Meditech Co., Ltd. Free Cash Flow is USD -12.86 M for the year ending December 31, 2023, a -24.84% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Guangdong Biolight Meditech Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -10.30 M, a 20.96% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD -13.03 M, a -121.96% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 59.34 M, a 1,100.29% change year over year.
  • Guangdong Biolight Meditech Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 4.94 M, a 282.69% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Shenzhen Stock Exchange: 300246.SZ

Guangdong Biolight Meditech Co., Ltd.

CEO Mr. Jinyuan Yan
IPO Date July 19, 2011
Location China
Headquarters No. 2 Innovation First Road
Employees 1,419
Sector Health Care
Industries
Description

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.

StockViz Staff

January 15, 2025

Any question? Send us an email